Volume 31, Issue 9 pp. 1164-1170
Full Paper

Design, Synthesis, and Biological Evaluation of Novel Dual Inhibitors of Secretory Phospholipase A2 and Sphingomyelin Synthase

Xing Gao

Xing Gao

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China

Search for more papers by this author
Haojun Gong

Haojun Gong

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China

Search for more papers by this author
Peng Men

Peng Men

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China

Search for more papers by this author
Lu Zhou

Corresponding Author

Lu Zhou

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China, Tel.: 0086-021-51980117; Fax: 0086-021-51980125Search for more papers by this author
Deyong Ye

Corresponding Author

Deyong Ye

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China, Tel.: 0086-021-51980117; Fax: 0086-021-51980125Search for more papers by this author
First published: 03 April 2013
Citations: 3

Abstract

A novel series of eight SMS and sPLA2 dual inhibitors containing indole and α-amino cyanide fragments of different length and substitution position was synthesized and evaluated by three different in vitro assays. Biological evaluation showed that all compounds provided inhibitory effects against SMS (about 50% inhibition at 100 µmol/L) and sPLA2 (14–32 µmol/L). All the compounds had the SMS activity better than the positive control compound D609 in SMS2 homogenate, with compounds 5b and 5e ideal for liver homogenate and SMS2 high expression cell homogenate, respectively.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.